Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

1

Predictors for virologic response in management of chronic hepatitis B

Jung Min Lee, M.D. Sang Hoon Ahn, M.D.-

Clin Mol Hepatol. 2010;16(1):1-4. Published online March 26, 2010

DOI: https://doi.org/10.3350/kjhep.2010.16.1.1

View: 4260 Download: 29 Crossref: 1

7

The Korean Journal Of Clinical outcomes and development of hepatocellular carcinoma after HBsAg seroclearance in chronic hepatitis B patients

Ji Hoon Kim

Clin Mol Hepatol. 2009;15(3):383-390. Published online September 30, 2009

DOI: https://doi.org/10.3350/kjhep.2009.15.3.383

View: 3902 Download: 15

3

Efficacy of 48-week clevudine therapy for chronic hepatitis B

Min Hwan Kim, M.D., Kyung-Ah Kim, M.D., June Sung Lee, M.D., Hyun Woong Lee, M.D. Hyung Joon Kim, M.D. Sang Gu Yun, M.D., Nam-Hoon Kim, M.D., Won Ki Bae, M.D., Young Soo Moon, M.D.

Clin Mol Hepatol. 2009;15(3):331-337. Published online September 30, 2009

DOI: https://doi.org/10.3350/kjhep.2009.15.3.331

View: 4992 Download: 23 Crossref: 8

Analysis of the cost-effectiveness of antiviral therapies in chronic hepatitis B patients in Korea

Byung Kook Kim, M.D., So Young Kwon, M.D., Chang Hong Lee, M.D., Won Hyeok Choe, M.D., Hong Mi Choi, M.S. Hye Won Koo, M.D.

Clin Mol Hepatol. 2009;15(1):25-41. Published online March 31, 2009

DOI: https://doi.org/10.3350/kjhep.2009.15.1.25

View: 5429 Download: 55 Crossref: 3

The efficacy of adefovir dipivoxil monotherapy and the incidence of genotypic resistance to adefovir dipivoxil in patients with Lamivudine-resistant chronic hepatitis B infection

Jae Hyeon Moon , Mong Cho , Ki Tae Yoon , Jung Ho Bae , Jeong Heo , Gwang Ha Kim , Dae Hwan Kang , Geun Am Song

Clin Mol Hepatol. 2008;14(4):503-512. Published online December 31, 2008

DOI: https://doi.org/10.3350/kjhep.2008.14.4.503

View: 4356 Download: 16 Crossref: 2

2

HBV Mutations During Antiviral Therapy in Patients with Chronic Hepatits B

Seong Gyu Hwang

Clin Mol Hepatol. 2005;11(4):311-319. Published online January 1, 1970

View: 2473 Download: 14

3

Clinical Outcomes after Discontinuation of Lamivudine in Chronic Hepatitis B Patients with Lamivudine Resistant HBV Mutant

Jeong Ki Kim, M.D. Seong Gyu Hwang, M.D. Hyeuk Park, M.D. Hong Youp Choi, M.D. Hyo Jin Cho, B.S. Kwang Hyun Ko, M.D. Sung Pyo Hong, M.D. Pil Won Park, M.D. Nam Keun Kim, Ph.D. and Kyu Sung Rim, M.D.

Clin Mol Hepatol. 2005;11(3):227-242. Published online January 1, 1970

View: 3120 Download: 14

2

Treatment of Chronic Hepatitis B ; The Efficacy of Alpha-Interferon in Korean Patiens with Chronic Hepatitis B

Kwang Cheol Koh

Clin Mol Hepatol. 2005;11(1):31-33. Published online January 1, 2000

View: 2481 Download: 14

Treatment of Chronic Hepatitis B ; The Efficacy of Lamivudine in Korean Patients with Chronic Hepatitis B

Jong Young Choi

Clin Mol Hepatol. 2005;11(1):25-30. Published online January 1, 2000

View: 2464 Download: 12

Treatment of Chronic Hepatitis B ; Indication of Drug Therapy in Patients with Chronic Hepatitis B

Mong Cho

Clin Mol Hepatol. 2005;11(1):1-8. Published online January 1, 2000

View: 2808 Download: 17

3

Pretreatment ALT Level and Histologic Activity as Predictors of HBeAg Loss in Lamivudine Treatment for Chronic Hepatitis B

Young Oh Kweon, M.D. and Kyung Hee Kang, M.D.

Clin Mol Hepatol. 2004;10(1):31-41. Published online January 1, 1970

View: 2651 Download: 14

Adequacy of Immediate Lamivudine Trial for Chronic Hepatitis B Patients with Acute Exacerbation

Chun Kyon Lee, M.D., Jeong Hun Suh, M.D., Yong Suk Cho, M.D., Sun Young Won, M.D. and In Suh Park, M.D.

Clin Mol Hepatol. 2004;10(1):22-30. Published online January 1, 1970

View: 2405 Download: 20

2

Therapeutic Strategy for YMDD Mutants of Hepatitis B Virus

Soo Hyung Ryu, M.D. and Young-Hwa Chung, M.D.

Clin Mol Hepatol. 2004;10(1):1-10. Published online January 1, 1970

View: 2641 Download: 17

3

Serum ALT and HBV DNA Levels in Patients with HBeAg-Negative Chronic Hepatitis B

Kyung Hwan Kim, M.D., Il Hwan Na, M.D., Jae Moon Cha, M.D., Yong Ki Cho, M.D., Se Young Park, M.D., Hyoung Pil Kim, M.D., Chul Soo Song, M.D., Jeong Heo, M.D. and Mong Cho, M.D.

Clin Mol Hepatol. 2003;9(4):284-292. Published online January 1, 2000

View: 3127 Download: 29

Efficacy of Lamivudine in Patients with Hepatitis B e Antigen-Negative Chronic Liver Diseases

In Du Jeong , Neung Hwa Park , Byung Chul Kim , Jee Hyun Park , Kwang Won Seo , Dae Hyun Kim , Kwang Ro Joo , Do Ha Kim

Clin Mol Hepatol. 2003;9(2):69-78. Published online January 1, 1970

View: 2857 Download: 11

Natural YMDD Motif Mutations of HBV Polymerase in the Chronic Hepatitis B Virus Infected Patients

Young Min Shin, M.D., Jeong Heo, M.D., Gwang Ha Kim, M.D., Dae Hwan Kang, M.D., Geun Am Song, M.D., Mong Cho, M.D., Ung Suk Yang, M.D., Cheol Min Kim, M.D. Hee Kyung Park, and Hyun Jung Jang

Clin Mol Hepatol. 2003;9(1):1-9. Published online January 1, 1970

View: 2674 Download: 15

Clinical and Virologic Characteristics of Lamivudine Resistance in HBV-associated Chronic Liver Disease

Sun Suk Kim, M.D., Moon Gi Chung, M.D., Ki Tak Ju, M.D., Dong Kyun Park, M.D. Oh Sang Kwon, M.D.,Yang Suh Koo, M.D., Yu Kyung Kim, M.D., Duck Ju Choi, M.D. Yu Jin Hwang, Ph.D.* and Ju Hyun Kim, M.D.

Clin Mol Hepatol. 2002;8(4):405-417. Published online January 1, 1970

View: 2341 Download: 15

Viral Breakthrough in HbeAg-Negative Chronic Hepatitis B Patients Receiving Lamivudine Therapy

Yun Jung Chang, M.D., Jeong Yoon Yim, M.D., Nam Young Cho, M.D., Chang Won Choi, M.D., Soo Jung Baek, M.D., Soo Hyun Ahn, M.D., Do Won Choi, M.D., Yong Dae Kwon, M.D., Sun Suk Kim, M.D.**, Oh Sang Kwon, M.D.**, Ju Hyun Kim, M.D.**, Jong Eun Yeon, M.D., Jin Won Song, M.D.*, Kwan Soo Byun, M.D. and Chang Hong Lee, M.D.

Clin Mol Hepatol. 2002;8(4):397-404. Published online January 1, 1970

View: 2692 Download: 18

Clinical Outcome in Cases of Viral Breakthrough During Lamivudine Therapy in Chronic Hepatitis B Patients

Soo Hyun Ahn, M.D., Yun Jung Chang, M.D., Seong Nam Oh, M.D., Do Won Choi, M.D., Soo Jung Baek, M.D., Won Seok Jeong, M.D., Chang Won Choi, M.D., Kyoung Oh Kim, M.D., Hyung Joon Yim, M.D., Nam Young Jo, M.D., Jong Jae Bak, M.D., Jae Seon Kim, M.D., Young-Tae Bak, M.D., Myung Seok Lee, M.D.*, Jong Eun Yeon M.D., Kwan Soo Byun, M.D. and Chang Hong Lee, M.D.

Clin Mol Hepatol. 2002;8(4):389-396. Published online January 1, 1970

View: 2390 Download: 17

Relationship Between Core Gene Mutations of Hepatitis B Virus and Response to Alpha Interferon Therapy in Chronic Hepatitis B

Byung Chul Yoo , Hyung Joon Kim , Jae Hyuk Do , Sill Moo Park

Clin Mol Hepatol. 2002;8(4):381-388. Published online January 1, 1970

View: 2430 Download: 24

Chemokine Receptor Expression of Hepatitis B Virus-Specific CD8⁺ Lymphocyte in Chronic B Viral Infection

Chun Kyon Lee, M.D. Jeong Hun Suh, M.D. Young Suk Cho, M.D. Kwang-Hyub Han, M.D. Jae Bock Chung, M.D. Chae Yoon Chon, M.D. and Young Myoung Moon, M.D.

Clin Mol Hepatol. 2002;8(4):363-370. Published online January 1, 2000

View: 2415 Download: 25

Direct Analysis of HBV - Specific CD8+ Lymphocyte By Tetrameric HLA-A2/core 18-27 Complex in Chronic Hepatitis B

Chun Kyon Lee, M.D., Jeong Hun Suh, M.D., Young Suk Cho, M.D., Kwang-Hyub Han, M.D.*, Jae Bock Chung, M.D.*, Chae Yoon Chon, M.D.*, Young Myoung Moon, M.D.*

Clin Mol Hepatol. 2002;8(2):139-148. Published online January 1, 1970

View: 2310 Download: 17

HBV DNA Levels, Aminotransferase and Histological Activity in Young Male Patients with HBeAg Positive Chronic Hepatitis B

Seung Chul Cho,Soong Hwan Lee,Joon Jae Shinn,Sung Hee Han,Byung Joo Roh,Joo Hyun Sohn,Dong Hoo Lee,Choon Suhk Kee

Clin Mol Hepatol. 2002;8(1):44-51. Published online January 1, 2000

View: 2769 Download: 28

Histopathologic Correlation between Chronic Hepatitis B and Nephropathy

Hyun Woong Lee, M.D., Chae Yoon Chon, M.D., Young Nyun Park, M.D.*, Kwan Sik Lee, M.D., Sang Hoon Ahn, M.D., Chang Hwan Choi, M.D., Young Soo Park, M.D., June-Won Cheong, M.D., Joo Hyuk Sohn, M.D., Jae Youn Cheong, M.D., Kun Hoon Song, M.D., Kwang-hyub Han, M.D., and Young Myoung Moon, M.D.

Clin Mol Hepatol. 2001;7(4):413-422. Published online January 1, 1970

View: 2665 Download: 20

Prevalence of HBV Genotypes in Korean Patients with Chronic Hepatitis B

Il Hyun Cho,Jung Youp Song,Deog Ki Kim,Hong Seok Lim,Seung Soo Sheen,Won Seok Kim,Kee Myeong Lee,Ki Baik Hahm,Jin Hong Kim,Sung Won Cho

Clin Mol Hepatol. 2001;7(4):381-386. Published online January 1, 1970

View: 3036 Download: 33

Efficacy of 1 - Year Lamivudine Treatment in the Patient of Chronic B Hepatitis and Liver Cirrhosis

Yong Song Kim,Seung Soo Kim,Hung Yong Jin,Myung Sin Ma,Seung Ok Lee,Soo Teik Lee,Dae Ghon Kim,Deuk Soo Ahn

Clin Mol Hepatol. 2001;7(2):171-180. Published online January 1, 2000

View: 2283 Download: 12

Lamivudine-Resistance in Patients with Chronic Hepatitis B and/or Cirrhosis and Detection of Mutations in YMDD Motif of Hepatitis B Virus Genome

Sung Ho Kang,Young Min Park,Jong Young Choi,Je Hyun Shin,Tae Wook Park,Si Hyun Bae,Byung Hun Byun,Byung Min Ahn,Chang Don Lee,Sang Bok Cha,Hee Sik Sun,Doo Ho Park,Boo Sung Kim

Clin Mol Hepatol. 2001;7(1):15-33. Published online January 1, 2000

View: 2532 Download: 16

Long - term Outcome of Chronic Hepatitis B According to the New Histological Classification

Byung Kyu Park M.D., Young Nyun Park M.D. Kwang-Hyub Han M.D., Sang Hoon Ahn M.D., Kwan Sik Lee M.D., Chae Yoon Chon M.D., Young Myoung Moon M.D., and Chanil Park M.D.

Clin Mol Hepatol. 2000;6(3):287-300. Published online January 1, 2000

View: 2174 Download: 19

The Effect of Lamivudine in HBV-positive Patients with Progressively Aggravating Chronic Liver Disease and Active HBV DNA Multiplication

Heon Ju Lee

Clin Mol Hepatol. 2000;6(1):73-81. Published online January 1, 2000

View: 2248 Download: 14

Emergence of YMDD Motif Mutant Hepatitis B Virus during Short-term Lamivudine Therapy

Yong Han Paik,Kwang Hyub Han,Hyo Young Chung,Chae Yoon Chun,Young Myoung Moon

Clin Mol Hepatol. 1999;5(3):173-183. Published online January 1, 2000

View: 4295 Download: 15

1 | 2 | 3 | 4 |

Viewed By 5013	MAFLD: How is it different from NAFLD?
Viewed By 4842	Evaluating the therapeutic efficacy of NAD supplementation in management of metabolic dysfunction-associated steatotic liver disease: Key considerations
Viewed By 4788	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 4494	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 4463	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 214	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 155	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 133	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 119	MAFLD: How is it different from NAFLD?
Cited By 96	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach

Search